PD-L1 expression in sebaceous carcinomas

被引：0
|
作者：
Maelle Saliba
Muhammad Shaheen
Rana El Hajj
Fatmeh Abbas
Shaarif Bashir
Umer Nisar Sheikh
Rami Mahfouz
Asif Loya
Ibrahim Khalifeh
机构：
[1] American University of Beirut Medical Center,Department of Pathology and Laboratory Medicine
[2] Shaukat Khanum Memorial Cancer Hospital and Research Centre,Department of Pathology
来源：
Cancer Immunology, Immunotherapy | 2021年 / 70卷
关键词：
Sebaceous carcinoma; PD-L1; Immunotherapy; Human papilloma virus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1907 / 1915
页数：8
相关论文
共 50 条
  • [21] PD-L1 EXPRESSION IS AN INDEPENDENT PROGNOSTIC FACTOR FOR SURVIVAL IN ENDOMETRIAL CARCINOMAS
    Zhang, S.
    Minaguchi, T.
    Shikama, A.
    Qi, N.
    Xu, C.
    Liu, S.
    Lachkar, B.
    Tasaka, N.
    Akiyama, A.
    Sakurai, M.
    Ochi, H.
    Satoh, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 81 - 81
  • [22] PD-L1 Expression in Thymomas and Thymic Carcinomas: Correlation with Clinicopathologic Features
    Odashiro, Patricia P.
    Orain, Michele
    Furrer, Daniela
    Diorio, Caroline
    Simonyan, David
    Moreira, Andre
    Joubert, Philippe
    LABORATORY INVESTIGATION, 2017, 97 : 487A - 487A
  • [23] PD-L1 Expression is Increased in Metastasizing Squamous Cell Carcinomas and Their Metastases
    Garcia-Diez, Irene
    Hernandez-Ruiz, Eugenia
    Andrades, Evelyn
    Gimeno, Javier
    Ferrandiz-Pulido, Carla
    Yebenes, Mireia
    Garcia-Patos, Vicenc
    Pujol, Ramon M.
    Hernandez-Munoz, Inmaculada
    Toll, Agusti
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2018, 40 (09) : 647 - 654
  • [24] Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous Carcinomas
    Zito Marino, Federica
    Rossi, Giulio
    Montella, Marco
    Botti, Gerardo
    De Cecio, Rossella
    Morabito, Alessandro
    La Manna, Carmine
    Ronchi, Andrea
    Micheli, Mariacarolina
    Salatiello, Giuseppe
    Micheli, Pietro
    Rocco, Danilo
    Accardo, Marina
    Franco, Renato
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (03) : 378 - 386
  • [25] PD-L1 Expression in Thymomas and Thymic Carcinomas: Correlation with Clinicopathologic Features
    Odashiro, Patricia P.
    Orain, Michele
    Furrer, Daniela
    Diorio, Caroline
    Simonyan, David
    Moreira, Andre
    Joubert, Philippe
    MODERN PATHOLOGY, 2017, 30 : 487A - 487A
  • [26] PD-L1 Expression and clinical Correlation in cutaneous Squamous Cell Carcinomas
    Schaper, K.
    Koether, B.
    Hesse, K.
    Satzger, I
    Gutzmer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 9 - 9
  • [27] MHC Class I and PD-L1 Expression in Pancreatic Ductal Carcinomas
    Gupta, Srishti
    Miller, Elisabeth
    Mills, Anne
    Stelow, Edward
    Raghavan, Shyam
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1505 - S1506
  • [28] PD-L1 expression and overall survival in high grade endometrial carcinomas
    Peiro-Marques, F. M.
    Ventero, M. P.
    Alenda, C.
    Lopez, J. A.
    Roman, M. J.
    Garcia, A.
    Acien, M. I.
    Martinez-Escoriza, J. C.
    VIRCHOWS ARCHIV, 2017, 471 : S92 - S92
  • [29] Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti PD-1/PD-L1 therapy
    Roberts, Jordan A.
    Gonzalez, Raul S.
    Das, Satya
    Berlin, Jordan
    Shi, Chanjuan
    HUMAN PATHOLOGY, 2017, 70 : 49 - 54
  • [30] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
12345